Bluestone Jeffrey
Director at GILD; Director at Provention Bio, Inc.
- Sold, on record
- $3.2M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Aug 20, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- GILDGILEAD SCIENCES, INC.Director
- Provention Bio, Inc.Director
Sales by reason
Form 4 sales per year, every sale on record.
Sales by company
- GILD26,788 shares
- Provention Bio, Inc.7,300 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice GILDNoticeJul 14, 2025 2025
Filed to sell 5,000 shares ($549k)
Bluestone Jeffrey, Director
10b5-1 planFiling
- 2 Form 4 sale GILDRoutineJul 14, 2025 same day
Sold 5,000 shares at $109.74 ($549k)
Bluestone Jeffrey, Director
10b5-1 planSold 35.9% of holdings ($1.5M position)8,920 shares leftFollows a Form 144Filing
- 3 Form 144 notice GILDNoticeNov 28, 2025 +137 days
Filed to sell 5,000 shares ($625k)
Bluestone Jeffrey, Director
No 10b5-1 planFiling
- 4 Form 4 sale GILDUnusualNov 28, 2025 same day
Sold 5,000 shares at $125.08 ($625k)
Bluestone Jeffrey, Director
No 10b5-1 planSold 35.9% of holdings ($1.7M position)8,920 shares leftFollows a Form 144Filing
- 5 Form 144 notice GILDNoticeJan 20, 2026 +53 days
Filed to sell 5,000 shares ($618k)
Bluestone Jeffrey, Director
10b5-1 plan1x usual sizeFiling
- 6 Form 4 sale GILDRoutineJan 20, 2026 same day
Sold 5,000 shares at $123.50 ($618k)
Bluestone Jeffrey, Director
10b5-1 planSold 35.9% of holdings ($1.7M position)8,920 shares left1x usual sizeFollows a Form 144Filing
- 7 Form 144 notice GILDNoticeAug 20, 2026 +212 days
Filed to sell 5,000 shares ($738k)
Bluestone Jeffrey, Director
10b5-1 plan1x usual sizeFiling
- 8 Form 4 sale GILDRoutineAug 20, 2026 same day
Sold 5,000 shares at $145.01 ($725k)
Bluestone Jeffrey, Director
10b5-1 planSold 33.2% of holdings ($2.2M position)10,066 shares left1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | Aug 21, 2026 | GILD | Director | Form 4 sale | 5,000 | $725k | 33.2% | Routine | SEC |
| Aug 20, 2026 | Aug 20, 2026 | GILD | Director | Form 144 notice | 5,000 | $738k | Notice | SEC | |
| Jan 20, 2026 | Jan 21, 2026 | GILD | Director | Form 4 sale | 5,000 | $618k | 35.9% | Routine | SEC |
| Jan 20, 2026 | Jan 20, 2026 | GILD | Director | Form 144 notice | 5,000 | $618k | Notice | SEC | |
| Nov 28, 2025 | Dec 1, 2025 | GILD | Director | Form 4 sale | 5,000 | $625k | 35.9% | Unusual | SEC |
| Nov 28, 2025 | Nov 28, 2025 | GILD | Director | Form 144 notice | 5,000 | $625k | Notice | SEC | |
| Jul 14, 2025 | Jul 15, 2025 | GILD | Director | Form 4 sale | 5,000 | $549k | 35.9% | Routine | SEC |
| Jul 14, 2025 | Jul 14, 2025 | GILD | Director | Form 144 notice | 5,000 | $549k | Notice | SEC | |
| Nov 26, 2024 | Nov 27, 2024 | GILD | Director | Form 4 sale | 6,788 | $620k | 43.2% | Unusual | SEC |
| Nov 26, 2024 | Nov 26, 2024 | GILD | Director | Form 144 notice | 6,788 | $620k | Notice | SEC | |
| Jun 17, 2019 | Jun 17, 2019 | Provention Bio, Inc. | Director | Form 4 sale | 7,300 | $87k | 49.9% | Unusual | SEC |